La Financiere De L'Echiquier Neurocrine Biosciences Inc Transaction History
La Financiere De L'Echiquier
- $2.22 Billion
- Q2 2024
A detailed history of La Financiere De L'Echiquier transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, La Financiere De L'Echiquier holds 22,015 shares of NBIX stock, worth $3.21 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
22,015
Previous 2,100
948.33%
Holding current value
$3.21 Million
Previous $289,000
948.44%
% of portfolio
0.14%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding NBIX
# of Institutions
632Shares Held
93.9MCall Options Held
632KPut Options Held
621K-
Black Rock Inc. New York, NY14.2MShares$2.07 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$1.46 Billion0.02% of portfolio
-
State Street Corp Boston, MA5.15MShares$751 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.57MShares$376 Million0.47% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.86MShares$272 Million3.62% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $14B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...